Home  >  Research  >  Labs  >  Cardiovascular Science and Diabetes Program  >  VASCULAR ENGINEERING


Cardiovascular disease (CVD) is the biggest killer of the developed world and one of the biggest health problems facing the developing world. Here, in Australia, the disease kills one person every 12 minutes and in the USA the number is much higher. In the Vascular Engineering laboratory we use both computational and experimental techniques to further our understanding of vascular physiology and disease, with an overall aim of helping tackle this global problem.

Our research can be broadly divided into the following themes:

  • Computational biomechanics
  • Experimental biomechanics
  • Multimodality imaging
  • 3D bioprinting and tissue engineering

More detailed information can be found at our website http://vasclab.mech.uwa.edu.au


Federal government supports new treatment to clear blocked arteries

A Western Australian medical research team developing a new treatment for cardiovascular disease has received $2,147,254 in Federal government funding to develop a first-ever drug to clear blocked arteries. The National Health and Medical Research Council (NHMRC) Ideas Grant for innovative research has been awarded to Associate Professor Juliana Hamzah…

Read More

WA researchers excel in nationally competitive grants

Eight (8) Federal government grants awarded to the Harry Perkins Institute of Medical Research Two of Australia’s most significant research grants, given only to the nation’s highest performing researchers, have been awarded to Harry Perkins Institute of Medical Research scientists. Associate Director of the Institute, The University of Western Australia’s…

Read More

AI stethoscope to help detect early signs of heart disease

New AI stethoscope could revolutionise medicine and help detect the early signs of heart valve disease A digital stethoscope that will easily be able to detect early signs of heart valve disease through the use of sophisticated artificial intelligence algorithms could be available to physicians by the end of this…

Read More